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ABSTRACT 
Factors such as: patient age, place of residence, socioeconomic status, cause of kidney failure, prognosis, 
duration of dialysis and co-morbidities influence transplantation outcome. Also the quality of available 
donors must be taken into account when looking for the balance between utility and justice. In the USA, 
UK and Portugal deceased donor kidney allocation rules are based on systems of points assigned to each 
possible receptor. However, the key factor in organ allocation is time on dialysis (first come, first served 
basis). The discussion about access to kidney transplantation with deceased donors never comes to a close 
and must be done clearly and systematically in order to enable the best decisions at any given moment.
Key-words: Organ allocation system; kidney transplant.
RESUMO 
Tendo em conta o fato de que o dador cadáver de órgãos é um bem escasso, a sua distribuição deve 
ser equilibrada, a fim de maximizar a utilidade e justiça. Um sistema de distribuição de rins de dador 
cadáver deverá ser alicerçado em políticas transparentes. Deve ter em conta a relação entre oferta e procura, 
buscando um equilíbrio entre o benefício neto mais elevado de sobrevivência que pode ser fornecido por 
um determinado órgão e o tempo de espera dos candidatos a transplante (assim como a probabilidade de 
estes serem transplantados). Fatores como: idade do doente, local de residência, nível socioeconómico, 
causa de insuficiência renal, o prognóstico, o tempo de diálise e co-morbilidades influenciam os resultados 
do transplante. Também a qualidade dos dadores disponíveis deve ser considerada quando se olha para 
o equilíbrio entre a utilidade e justiça na distribuição dos órgãos. Nos EUA, Reino Unido e Portugal as 
regras de alocação de rins de dadores cadáver são baseados em sistemas de pontos atribuídos a cada 
possível receptor. No entanto, o fator-chave na alocação de órgãos é o tempo em diálise (numa base: 
primeiro a chegar, primeiro a ser servido). A discussão sobre o acesso ao transplante renal de dador cadáver 
é constante e deve ser feita de forma clara e sistemática, de modo a permitir as melhores decisões em 
todos os momentos.
Palavras-chave: Sistema de alocação de órgãos; Transplante Renal.
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INTRODUCTION 
For patients with end stage renal disease, kidney 
transplantation provides a lower mortality, reduction 
of cardiovascular problems and a better quality of life 
compared with those on dialysis, even for those with 
advanced age or co-morbidities1. In light of the fact 
that deceased donor organs are a scarce resource, 
their distribution must be balanced in order to maxi-
mize utility and justice2. Criteria such as: clinical 
urgency, waiting time, diagnosis, duration of ischaemia, 
transplant outcomes, number of organs available for 
paediatric transplants, transplantation in the elderly, 
time on dialysis, human leukocyte antigen (HLA) com-
patibility and the presence or absence of HLA antibod-
ies; should and must always be taken into account 
when discussing access to kidney transplantation3.
An allocation system for deceased donor kidneys 
should be anchored to transparent policies. It should 
take into account the relationship between supply and 
demand, hence seeking a balance between the higher 
net benefit of survival that can be provided by a par-
ticular organ and the transplant candidates’ waiting time 
(as well as the probability of being transplanted)4.
 A NEW KIDNEY ALLOCATION  
SYSTEM
If one assumes a utilitarian standpoint, the goal is 
to maximize the overall benefit that can be drawn from 
an available organ. From the standpoint of access equal-
ity, all transplant candidates should have the same 
opportunities to receive an organ, regardless of the post-
transplant outcome5, assuming that a particular organ 
being distributed is equally a good choice and non-
damaging to all the candidates (primum non nocere).
Factors such as: patient age, place of residence, 
socioeconomic status, cause of kidney failure, prog-
nosis, duration of dialysis and co-morbidities influence 
transplantation outcome1. Also the quality of available 
donors must be taken into account when looking for 
that balance between utility and justice.
A numerical indicator of the donor risk applicable 
to any donor at any time gives clinicians an idea of 
what they can expect from a particular transplant6. 
This kind of index would also aid in education of 
transplant candidates as far as the potential benefit 
of a transplant from a living donor compared with 
deceased donor transplantation7, making them more 
aware of the advantages of the first.
A kidney distribution based only on the number 
of HLA compatibility, although it may be efficient, 
will result in longer patients’ waiting times for trans-
plantation (due to patients with rare HLA typing). 
This inequality resulting from the strict criteria of 
HLA compatibility has been recognized in several 
countries leading to changes in their respective organ 
allocation systems8. Portugal has also followed suit 
and attempted to correct this issue with Ordinance 
nº 6537/2007 put into effect April 3rd 9.
Nowadays, many deceased donor distribution pro-
tocols are based on candidates’ waiting time (or 
time on dialysis) not taking into account graft and 
patient post-transplant survival 2.
In the USA, UK and Portugal deceased donor kidney 
allocation rules are based on systems of points 
assigned to each possible receptor. However, the key 
factor in organ allocation is time on dialysis (first come, 
first served basis)8,10. Assigning kidneys to patients 
who have longer time on dialysis, are sicker or are 
more sensitized to HLA antibodies, without regard to 
the compatibility with the donor, has had the negative 
effect of increasing the graft rejection rate and reducing 
the number of transplanted patients11-13.
The presence of donor specific antibodies (DSA) anti-
HLA is a recipient’s immunologic risk factor14 and a risk 
for graft acute rejection15. Identification of DSA (defined 
by solid phase techniques) clinically relevant for trans-
plantation is one of the current challenges of histocom-
patibility16,17. Transplanted patients with DSA are gener-
ally subjected to more intense immunosuppression 
regimens16. Also in the long run results of transplanta-
tion show that they are worse in patients with pre-
existing DSA than in those without such antibodies18.
Anti-HLA sensitized candidates are more likely to 
have a positive crossmatch (usually a contraindication 
of transplant) with an available donor for transplanta-
tion. The definition of a calculated panel-reactive 
antibody value (cPRA) based on non-acceptable HLA 
for which the patient is sensitized is an indicator for 
the probability of transplantation and for the difficulty 
of patient’s access to transplant19,20. The cPRA is a 
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more accurate and trustworthy measure for wait listed 
sensitized patients candidates than the one currently 
in use in Portugal (complement-dependent cytotoxity 
PRA)21. To avoid transplant difficulties in hypersen-
sitized candidates (PRA > 85%), they used to be 
prioritized in the distribution of deceased donor kid-
neys3 or are benefited with extra points20.
The quest for a deceased donor allocation system 
should be a continuous process, as exemplified by the 
rules of the European Kidney Allocation System. From 
the time of its introduction in 1996, it has been con-
tinuously redefined in order to: reduce the maximum 
waiting time for a transplant, balance the exchange of 
organs between countries that are part of the program, 
and look for the HLA ensuring the success of trans-
plants22. A transparent kidney allocation system requires 
stating which patients are likely to be at a disadvantage 
as far as access to transplantation23.
The point system from the Portuguese rules for 
the selection of donor-recipient pair in transplanta-
tion with cadaveric donors, implemented in August 
2007, is opaque and tends to over select patients 
with longer time on dialysis9. These rules have also 
been associated with an augmentation in the number 
of acute rejections13.
As an alternative to the existing allocation system, 
we propose a colour system classification (Table I) that 
will allow clinicians to know the position of a particular 
patient in the access to kidney transplantation at all 
times. Red will be attributed to all clinically urgent 
candidates, as is already defined by the current rules 
(“patient with terminal chronic renal failure without 
possibility of constructing definitive vascular access for 
whom peritoneal dialysis is not possible”). Orange 
would be allocated to candidates with values of cPRA 
> 85% or their time on dialyses being higher than the 
third quartile of wait listed patients’ time on dialysis 
to transplantation (i.e., how long it takes for 75% of 
wait-listed candidates to receive a transplant). Yellow 
would be given to candidates with cPRA > 50% or time 
on dialysis being higher than the median of wait listed 
patients’ time on dialysis to transplantation (i.e., how 
long it takes for 50% of wait-listed candidates to receive 
a transplant). Green will be for the remaining candidates. 
Within each colour group, the candidates order will be 
determined taking into account the number of HLA 
compatibilities with the donor and, if a tie still persists, 
the decision is made by the time on dialysis.
It tends to be a common practice in many countries 
to allocate organs of extended criteria donors (ECD) 
(aged 60 years or over 50, plus two of three condi-
tions: a history of hypertension, serum creatinine 
levels greater than 1.5 mg/dL, or cerebrovascular 
cause of death) to older candidates expected to live 
less time24,25. Organs from older donors may also 
be particularly suitable for older recipients which 
have a smaller muscle mass and reduced immuno-
reactivity enabling the use of less aggressive immu-
nosuppressive regimens26.
This proposed colour system could also be applied 
in a manner similar to the Eurotransplant “old for old” 
programme22, i.e., organs from ECD would be allocated 
to recipients older than 65 years, while organs from 
the other donors would be allocated to recipients aged 
65 or less. The proposed colour system would be 
applied in both cases for candidate ordering.
High-risk renal transplant candidates have a very 
poor prognosis while waiting for a transplant, on 
the other hand, healthier candidates benefit from 
waiting for a more appropriate donor, even when 
subjected to a longer time on dialysis27. The pos-
sibility of organs with a shorter life expectancy being 
allocated to candidates with shorter life expectancy 
has been advocated by many8. This would facilitate 
better organ designation to better candidates thus 
providing a more efficient organ allocation system, 
in which organs that are expected to function for 
many years are assigned to patients with a greater 
life expectancy10.
Table I
Kidney allocation colour system
Not ECD ECD
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Clinically Urgent RED Clinically Urgent
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cPRA ≥ 85% 
or ToD ≥ 3rd Quartile1
ORANGE
cPRA ≥ 85% or ToD ≥ 
3rd Quartile1
cPRA ≥ 50% 
or ToD ≥ Median1
YELLOW
cPRA ≥ 50% or ToD ≥ 
Median1
cPRA < 50% 
and ToD < Median1
GREEN
cPRA < 50% and ToD < 
Median1
ECD – Extended Criteria Donor; cPRA – calculated PRA; ToD – time on dialysis
1 wait listed patients’ time from first dialysis to transplantation
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CONCLUSION 
Although it must be validated with real data, this 
proposed new allocation system for kidney transplanta-
tion has the advantage of being more transparent than 
the current Portuguese rules; with it clinicians can 
explain to the patient in a more intuitive manner how 
far they are from being transplanted. Also, the realiza-
tion that patients classified as green will likely wait 
too long for an organ, can easily sway them toward 
the solution of transplantation with a living donor.
This system of colours also takes into account the 
criteria of utility and justice for kidney distribution. By 
setting only 4 colour groups on the basis of justice 
(time on dialysis and probability of transplantation) 
and, within each of these groups, candidates are ordered 
based by efficiency (HLA compatibilities); the proposed 
criteria meant to be balanced. Whenever the risk of a 
poor transplant outcome exists and is predictable, this 
fact must be explained to the patient. That responsibility 
should be shared using an informed signed consent.
The discussion about access to kidney transplanta-
tion with deceased donors never comes to a close 
and must be done clearly and systematically in order 
to enable the best decisions at any given moment.
Conflict of interest statement. None declared.
References
 1. Pussell BA, Bendorf A, Kerridge IH. Access to the kidney transplant waiting list: a time 
for reflection. Intern Med J 2012;42(4):360-363.
 2. Freeman RB, Jr. Survival benefit: quality versus quantity and trade-offs in developing 
new renal allocation systems. Am J Transplant 2007;7(5):1043-1046.
 3. Persijn GG. Allocation of organs, particularly kidneys, within Eurotransplant. Hum 
Immunol 2006;67(6):419-23.
 4. Bengochea M, Alvarez I, Toledo R, Carretto E, Forteza D. Review of the Uruguayan 
Kidney Allocation System: the solution to a complex problem, preliminary data. 
Transplant Proc 2010;42(1):211-215.
 5. Stegall MD. Developing a new kidney allocation policy: the rationale for including life 
years from transplant. Am J Transplant 2009;9(7):1528-1532.
 6. Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS. Kidney and pan-
creas transplantation in the United States, 1996-2005. Am J Transplant 2007;7(5 Pt 
2):1359-1375.
 7. Andreoni KA. Educating kidney transplant professionals and candidates may improve 
utilization, allocation efficiency and lifetime survival. Am J Transplant 2010;10(4):711-712.
 8. Courtney AE, Maxwell AP. The challenge of doing what is right in renal transplan-
tation: balancing equity and utility. Nephron Clin Pract 2009;111(1):c62-67; discus-
sion c8.
 9. Lima BA, Mendes M, Alves H. Kidney transplantation in the north of Portugal: donor 
type and recipient time on dialysis. Port J Nephrol Hypert 2013;27(1):23-30.
 10. Segev DL. Evaluating options for utility-based kidney allocation. Am J Transplant 
2009;9(7):1513-1518.
 11. Norman DJ. The kidney transplant wait-list: allocation of patients to a limited supply 
of organs. Semin Dial 2005;18(6):456-459.
 12. Heinold A, Opelz G, Döhler B, et al. Deleterious impact of HLA-DRB1 allele mismatch 
in sensitized recipients of kidney retransplants. Transplantation 2013;95(1):137-141.
 13. Goncalves JA, Jorge C, Atalaia A, et al. New law of renal transplantation in Portugal 
associated with more acute rejection episodes and higher costs. Transplant Proc 
2012;44(8):2276-2279.
 14. Mohan S, Palanisamy A, Tsapepas D, et al. Donor-specific antibodies adversely affect 
kidney allograft outcomes. J Am Soc Nephrol 2012;23(12):2061-2071.
 15. Tambur AR, Leventhal J, Kaufman DB, Friedewald J, Miller J, Abecassis MM. Tailoring 
antibody testing and how to use it in the calculated panel reactive antibody era: the 
Northwestern University experience. Transplantation 2008;86(8):1052-1059.
 16. Gupta A, Sinnott P. Clinical relevance of pretransplant human leukocyte antigen donor-
specific antibodies in renal patients waiting for a transplant: a risk factor. Hum 
Immunol 2009;70(8):618-622.
 17. Gloor JM. The utility of comprehensive assessment of donor specific anti-HLA antibod-
ies in the clinical management of pediatric kidney transplant recipients. Pediatr 
Transplant 2011;15(6):557-563.
 18. Lefaucheur C, Loupy A, Hill GS, et al. Preexisting donor-specific HLA antibodies predict 
outcome in kidney transplantation. J Am Soc Nephrol 2010;21(8):1398-1406.
 19. Cecka JM. Calculated PRA (CPRA): the new measure of sensitization for transplant 
candidates. Am J Transplant 2010;10(1):26-29.
 20. Lima BA, Mendes M, Alves H. Hypersensitized candidates to kidney transplantation in 
Portugal. Port J Nephrol Hypert 2013;27(2):77-81.
 21. Cecka JM, Kucheryavaya AY, Reinsmoen NL, Leffell MS. Calculated PRA: initial results 
show benefits for sensitized patients and a reduction in positive crossmatches. Am J 
Transplant 2011;11(4):719-724.
 22. Mayer G, Persijn GG. Eurotransplant kidney allocation system (ETKAS): rationale and 
implementation. Nephrol Dial Transplant 2006;21(1):2-3.
 23. Petrini C. Kidney allocation for transplantation: some aspects of ethics and compara-
tive law. Transplant Proc 2012;44(7):1812-1814.
 24. Snanoudj R, Rabant M, Timsit MO, et al. Donor-estimated GFR as an appropriate 
criterion for allocation of ECD kidneys into single or dual kidney transplantation. Am 
J Transplant 2009;9(11):2542-2551.
 25. Messina M, Fop F, Gallo E, Tamagnone M, Segoloni GP. Analysis of four scoring 
systems and monocentric experience to optimize criteria for marginal kidney trans-
plantation. Transplant Proc 2010;42(6):2209-2213.
 26. Veroux P, Veroux M, Puliatti C, et al. Kidney transplantation from cadaveric donors 
unsuitable for other centers and older than 60 years of age. Transplant Proc 
2005;37(6):2451-2453.
 27. Schold JD, Meier-Kriesche HU. Which renal transplant candidates should accept mar-
ginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc 
Nephrol 2006;1(3):532-538.
Correspondence to:
Dr. Bruno A. Lima
Rua Miguel Bombarda, 681, 1º Centro Frente
4445 Ermesinde, Portugal
E-mail: balima78@gmail.com
Bruno A Lima, Miguel Mendes, Helena Alves
Nefro - 27-4 - Opinion - Kidney transplant allocation.indd   4 09-12-2013   17:56:14
